Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells-Reference-Cited by-同舟云学术

Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells

Published:2018-12-04 Issue:23 Volume:138 Page:2666-2681
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Ma Ning¹²³,Zhang Joe Z.¹²³,Itzhaki Ilanit¹²³,Zhang Sophia L.¹²³,Chen Haodong¹²³,Haddad Francois¹²³,Kitani Tomoya¹²³,Wilson Kitchener D.¹²³,Tian Lei¹²³,Shrestha Rajani¹²³,Wu Haodi¹²³,Lam Chi Keung¹²³,Sayed Nazish¹²³,Wu Joseph C.¹²³

Affiliation:

1. Stanford Cardiovascular Institute (N.M., J.Z.Z., I.I., S.L.Z., H.C., F.H., T.K., K.D.W., L.T., R.S., H.W., C.L., N.S., J.C.W.)

2. Division of Cardiology, Department of Medicine (N.M., J.Z.Z., I.I., S.L.Z., H.C., F.H., T.K., K.D.W., L.T., R.S., H.W., C.L., N.S., J.C.W.)

3. Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, CA (N.M., J.Z.Z., I.I., S.L.Z., H.C., F.H., T.K., K.D.W., L.T., R.S., H.W., C.L., N.S., J.C.W.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference46 articles.

1. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

2. Understanding of BRCA VUS genetic results by breast cancer specialists

3. Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation

4. Clinical Interpretation and Recommendations for Patients with a Variant of Uncertain Significance in BRCA1 or BRCA2: A Survey of Genetic Counseling Practice

5. Genetics of Hypertrophic Cardiomyopathy After 20 Years

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity;International Journal of Molecular Sciences;2024-08-24

2. Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells;International Journal of Molecular Sciences;2024-08-09

3. Generation of induced pluripotent stem cells from an individual with early onset and severe hypertrophic cardiomyopathy linked to MYBPC3: c.772G > A mutation;Human Cell;2024-05-18

4. Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model;F1000Research;2024-02-12

5. Generation of an Induced Pluripotent Stem Cell Line ICGi045-A of a RASopathy Patient Carrying p.Glu329Lys Variant in SOS1;Russian Journal of Developmental Biology;2024-02